Hjem › B-celle lymfom
B-celle lymfom kliniske forsøg rekrutterer i USA
67 studier for B-celle lymfom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- New York City, NY19 studier
- Houston, TX16 studier
- Chicago, IL12 studier
- Philadelphia, PA11 studier
- Nashville, TN11 studier
- Rochester, MN10 studier
- Milwaukee, WI9 studier
- Baldwin Park, CA9 studier
- Cleveland, OH9 studier
- Salt Lake City, UT8 studier
- Boston, MA8 studier
- Pittsburgh, PA7 studier
- Columbus, OH7 studier
- Charlotte, NC7 studier
- Seattle, WA7 studier
- Washington, DC7 studier
- Dallas, TX7 studier
- Denver, CO7 studier
- San Antonio, TX6 studier
- Aurora, CO6 studier
- New Haven, CT6 studier
- Edison, NJ6 studier
- Atlanta, GA6 studier
- Los Angeles, CA6 studier
- Portland, OR5 studier
- St. Louis, MO5 studier
- Kansas City, MO5 studier
- Mountain View, CA5 studier
- Omaha, NE5 studier
- Ann Arbor, MI5 studier
- Tampa, FL4 studier
- Jacksonville, FL4 studier
- Richmond, VA4 studier
- Indianapolis, IN4 studier
- Winston-Salem, NC4 studier
- Cedar Rapids, IA4 studier
- Miami, FL4 studier
- Louisville, KY4 studier
- Cincinnati, OH4 studier
- Austin, TX3 studier
Efter delstat
- Arizona5 studier
- Californien20 studier
- Colorado11 studier
- Connecticut6 studier
- District of Columbia3 studier
- Florida15 studier
- Georgia8 studier
- Illinois12 studier
- Indiana5 studier
- Iowa6 studier
- Kansas9 studier
- Kentucky4 studier
- Maryland7 studier
- Massachusetts8 studier
- Michigan7 studier
- Minnesota12 studier
- Missouri5 studier
- Nebraska5 studier
- New Jersey9 studier
- New York21 studier
- North Carolina11 studier
- Ohio17 studier
- Oregon6 studier
- Pennsylvania16 studier
- Tennessee13 studier
- Texas26 studier
- Utah8 studier
- Virginia8 studier
- Washington10 studier
- Wisconsin10 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06343311Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservationsstudie
Alder 0 til 38 · Alle køn · Opdateret 1. okt. 2026 · NCT06131801CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
RekruttererFase 1/2
Alder 3 til 39 · Alle køn · Opdateret 30. sep. 2026 · NCT05442515A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06742996A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07439653Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06350318Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
RekruttererFase 2
Alder 60 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06052826A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06213311A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07101328A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT05615636A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
RekruttererFase 1
Alder 0 til 18 · Alle køn · Opdateret 16. sep. 2026 · NCT06173518UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
RekruttererFase 1/2
31 Days – 30 Years · Alle køn · Opdateret 14. sep. 2026 · NCT04544592Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06526793A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06634589Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT05272384Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07225439A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06564038A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06393738Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
RekruttererObservationsstudie
Alder 4 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07652580Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07516093A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07123454Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07520006A Study of ARC-02 in B-cell NHL
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT07691606Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 25. aug. 2026 · NCT05389423Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT05826535Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.